FDA relents from midodrine withdrawal plan
Monday, September 6, 2010 - 12:21
in Health & Medicine
(AP) -- Federal regulators have backed off a plan to remove a Shire PLC low blood-pressure treatment from the market after warning in August that the drug has not been proven effective.